Evidence map›Paper›PMID 30355080›Full record

ReviewCirculation research2018

Mechanisms of Vascular Aging.

Zoltan Ungvari, Stefano Tarantini, Anthony J Donato, Veronica Galvan, Anna Csiszar

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Circulation research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06389149 (Leg Exercise Assistive Paddling), which is not on this map. Cited by 572 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
572citing papers in PubMed, 9 pooled it
20.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06389149 nawithdrawnnot on this mapstarted 2024, after this paper: background citation

Leg Exercise Assistive Paddling (LEAP) Therapy for Peripheral Artery Disease

TypeinterventionalSponsorUniversity of NebraskaRan2024 to 2026Enrolled0ConditionsPeripheral Arterial Disease, Peripheral Vascular Disease, Peripheral Artery Occlusive Disease, Peripheral Artery DiseaseArmsLEAP therapy, no LEAP therapy
3 · Its place in the literature

Who cites it

572 citing papers in PubMed, 9 syntheses or guidelines pooled it, 827 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Direct Vascular Effects of Angiotensin II (A Systematic Short Review).International journal of molecular sciences · 2024
    Pooled it
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

512 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Zoltan UngvariFrom the Vascular Cognitive Impairment Laboratory, Reynolds Oklahoma Center on Aging (Z.U., S.T., A.C.), University of Oklahoma Health Sciences Center, Oklahoma City.
Stefano TarantiniFrom the Vascular Cognitive Impairment Laboratory, Reynolds Oklahoma Center on Aging (Z.U., S.T., A.C.), University of Oklahoma Health Sciences Center, Oklahoma City.
Anthony J DonatoDivision of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City (A.J.D.).
Veronica GalvanBarshop Institute for Longevity and Aging Studies (V.G.), University of Texas Health Science Center at San Antonio.
Anna CsiszarFrom the Vascular Cognitive Impairment Laboratory, Reynolds Oklahoma Center on Aging (Z.U., S.T., A.C.), University of Oklahoma Health Sciences Center, Oklahoma City.
University of Oklahoma Health Sciences Center · USGeriatric Research Education and Clinical Center · US

Funding

TRANSGENIC COREP30AG013319 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI JAMES FLOYD NELSON · 1995 to 2026
$30.6M
GEROSCIENCE TRAINING PROGRAM IN OKLAHOMAT32AG052363 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Benjamin Francis Miller, William Edmund Sonntag · 2017 to 2026
$3.6M
Effects of Radiation on Brain Microvasculature and CognitionR01NS056218 · NINDS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CSISZAR, ANNA, SONNTAG, WILLIAM EDMUND · 2007 to 2018
$3.6M
NOVEL APPROACHES FOR REGULATION OF IGF-1 LEVELS THROUGHOUT THE LIFESPANR01AG038747 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI SONNTAG, WILLIAM EDMUND · 2011 to 2015
$2.4M
Cerebral microhemorrhages and gait dysfunction in agingR01AG055395 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CSISZAR, ANNA · 2017 to 2025
$2.3M
Brain cellular senescence as a driver of Alzheimers DiseaseRF1AG057964 · NIA · OREGON STATE UNIVERSITY · PI GALVAN, VERONICA, MAGNUSSON, KATHY R · 2017 to 2019
$2.3M
Radiation-induced astrocyte dysfunction and cognitive declineR01NS100782 · NINDS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI UNGVARI, ZOLTAN ISTVAN · 2018 to 2022
$1.7M
Novel Methodology for Identification of Senolytics that Reduce Age-related Disease and DysfunctionR44AG053131 · NIA · RECURSION PHARMACEUTICALS, LLC · PI DONATO, ANTHONY JOHN, GIBSON, CHRISTOPHER · 2016 to 2020
$1.6M
Telomere uncapping and arterial dysfunction: Novel mechanism and implications for agingR01AG050238 · NIA · UNIVERSITY OF UTAH · PI DONATO, ANTHONY JOHN · 2016 to 2020
$1.6M
Microvascular mechanisms of neuroinflammation: role of Nrf2R01AG047879 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CSISZAR, ANNA · 2014 to 2018
$1.5M
Amelioration of aged endothelial dysfunction by NAMPT and caloric restrictionK02AG045339 · NIA · UNIVERSITY OF UTAH · PI DONATO, ANTHONY JOHN · 2014 to 2018
$558k
Role of polyphosphate in Alzheimer's DiseaseR21AG055090 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JAKOB, URSULA H. · 2017 to 2018
$439k
BLRD VA I01 BX002211NIA NIH HHS K02 AG045339NIA NIH HHS P30 AG013319NIA NIH HHS R01 AG038747NIA NIH HHS R01 AG047879NIA NIH HHS R01 AG050238NIA NIH HHS R01 AG055395NIA NIH HHS R21 AG055090NIA NIH HHS R44 AG053131NIA NIH HHS RF1 AG057964NIA NIH HHS T32 AG052363NINDS NIH HHS R01 NS056218NINDS NIH HHS R01 NS100782
6 · The paper itself

Abstract

Aging of the vasculature plays a central role in morbidity and mortality of older people. To develop novel treatments for amelioration of unsuccessful vascular aging and prevention of age-related vascular pathologies, it is essential to understand the cellular and functional changes that occur in the vasculature during aging. In this review, the pathophysiological roles of fundamental cellular and molecular mechanisms of aging, including oxidative stress, mitochondrial dysfunction, impaired resistance to molecular stressors, chronic low-grade inflammation, genomic instability, cellular senescence, epigenetic alterations, loss of protein homeostasis, deregulated nutrient sensing, and stem cell dysfunction in the vascular system are considered in terms of their contribution to the pathogenesis of both microvascular and macrovascular diseases associated with old age. The importance of progeronic and antigeronic circulating factors in relation to development of vascular aging phenotypes are discussed. Finally, future directions and opportunities to develop novel interventions to prevent/delay age-related vascular pathologies by targeting fundamental cellular and molecular aging processes are presented.

Indexed as

Cellular SenescenceOxidative StressAge FactorsAgingAnimalsArteriesCardiovascular DiseasesEnergy MetabolismEpigenesis, GeneticGenomic InstabilityHumansInflammation MediatorsMitochondriaPhenotypeProteostasisSignal TransductionInflammation Mediatorsatherosclerosisinflammationphenotypeproteostasisstem cells

Identifiers

PMID30355080
PMCPMC6248882
OpenAlexW2891919070

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.